328 related articles for article (PubMed ID: 37247759)
1. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
[TBL] [Abstract][Full Text] [Related]
2. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
Sommer S; Ritterhoff T; Melchior F; Mootz HD
Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
[TBL] [Abstract][Full Text] [Related]
3. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
[TBL] [Abstract][Full Text] [Related]
4. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
Yang WS; Campbell M; Kung HJ; Chang PC
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
[TBL] [Abstract][Full Text] [Related]
6. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
[TBL] [Abstract][Full Text] [Related]
7. Identification of a non-covalent ternary complex formed by PIAS1, SUMO1, and UBC9 proteins involved in transcriptional regulation.
Mascle XH; Lussier-Price M; Cappadocia L; Estephan P; Raiola L; Omichinski JG; Aubry M
J Biol Chem; 2013 Dec; 288(51):36312-27. PubMed ID: 24174529
[TBL] [Abstract][Full Text] [Related]
8. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
[TBL] [Abstract][Full Text] [Related]
9. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
10. DNA repair and global sumoylation are regulated by distinct Ubc9 noncovalent complexes.
Prudden J; Perry JJ; Nie M; Vashisht AA; Arvai AS; Hitomi C; Guenther G; Wohlschlegel JA; Tainer JA; Boddy MN
Mol Cell Biol; 2011 Jun; 31(11):2299-310. PubMed ID: 21444718
[TBL] [Abstract][Full Text] [Related]
11. Sumoylation of human argonaute 2 at lysine-402 regulates its stability.
Sahin U; Lapaquette P; Andrieux A; Faure G; Dejean A
PLoS One; 2014; 9(7):e102957. PubMed ID: 25036361
[TBL] [Abstract][Full Text] [Related]
12. Ubc9 sumoylation regulates SUMO target discrimination.
Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
[TBL] [Abstract][Full Text] [Related]
13. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
14. Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism for SUMO paralog selection.
Tatham MH; Kim S; Jaffray E; Song J; Chen Y; Hay RT
Nat Struct Mol Biol; 2005 Jan; 12(1):67-74. PubMed ID: 15608651
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
[TBL] [Abstract][Full Text] [Related]
16. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
17. Role of two residues proximal to the active site of Ubc9 in substrate recognition by the Ubc9.SUMO-1 thiolester complex.
Tatham MH; Chen Y; Hay RT
Biochemistry; 2003 Mar; 42(11):3168-79. PubMed ID: 12641448
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms in SUMO conjugation.
Varejão N; Lascorz J; Li Y; Reverter D
Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
[TBL] [Abstract][Full Text] [Related]
19. SUMO: getting it on.
Anckar J; Sistonen L
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
[TBL] [Abstract][Full Text] [Related]
20. Noncovalent interaction between Ubc9 and SUMO promotes SUMO chain formation.
Knipscheer P; van Dijk WJ; Olsen JV; Mann M; Sixma TK
EMBO J; 2007 Jun; 26(11):2797-807. PubMed ID: 17491593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
